Guo et al. 2020
Featured Review: Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Tiantian Guo, ...,Timothy Y. Huang, Huaxi Xu & Yingjun Zhao
Suk & Rousseaux 2020
Featured Review: The role of TDP-43 mislocalization in amyotrophic lateral sclerosis.
Terry R. Suk & Maxime W. C. Rousseaux
Kaniyappan et al. 2020
Featured Research: FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
Senthilvelrajan Kaniyappan, Katharina Tepper, Jacek Biernat, ... & Eckhard Mandelkow
Fitz et al. 2020
Featured Research: Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
Nicholas F. Fitz, ..., Iliya Lefterov & Radosveta Koldamova
Articles
-
-
Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer’s disease
-
Glycosphingolipids and neuroinflammation in Parkinson’s disease
-
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers
-
Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
Editor highlights
ICMN2020 Conference
It is with regret we announce the cancellation of the 6th International Conference on Molecular Neurodegeneration, due to the unstable situation and travel restrictions surrounding the novel Coronavirus.
Please see the ICMN website for further details.
Parkinson's disease - a series of reviews
Molecular Neurodegeneration presents a new thematic series, collating reviews on recent advances in Parkinson's Disease research.
Guest Edited by Mark Cookson and Ted Dawson, reviews will continue to publish throughout 2020. The collection can be read here.
About Us
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Editors-in-Chief:
- Guojun Bu, Mayo Clinic, USA
- Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
Follow
Editors-in-Chief
Guojun Bu, Mayo Clinic, USA
Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
Annual Journal Metrics
-
Speed
43 days to first decision for reviewed manuscripts only
20 days to first decision for all manuscripts
121 days from submission to acceptance
23 days from acceptance to publication
Citation Impact
9.599 - 2-year Impact Factor
8.595 - 5-year Impact Factor
1.671 - Source Normalized Impact per Paper (SNIP)
4.040 - SCImago Journal Rank (SJR)
Usage
568,061 downloads
570 Altmetric mentions
